Loading…
Loading…
HYDI does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HYDI and 80,000+ other tickers.
See exactly how HYDI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HYDI and 80,000+ other tickers.
Hydromer, Inc. (HYDI) is a company dedicated to the full lifecycle of hydrophilic polymer-based solutions, from invention and patenting to manufacturing and global sales of both products and services. Its operations are divided into two primary divisions: Polymer Research and Medical Products. The company's diverse offerings include specialized medical coatings and related services, medical hydrogel formulations, and key ingredients for cosmetic products. Hydromer also develops advanced coatings for condensation control (specifically anti-fog and anti-frost applications), manufactures various…
Neo Performance Materials (OTCMKTS:NOPMF - Get Free Report) and Hydromer (OTCMKTS:HYDI - Get Free Report) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Profitability This table compares Neo Performance Materials
CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company's 2024 year-end financial reporting processes, reviews, audit, and potential adjustments, each of which could result in changes to the numbers reported.
� Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions
CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to change upon the completion of the Company's 2024 year-end financial reporting processes, reviews and audit. Any resulting adjustments could result in changes to the numbers reported, including material changes.
CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company's 2024 year-end financial reporting processes, reviews, audit, and potential adjustments, each of which could result in changes to the numbers reported.